Abstract Submission

Abstract Submission will be open as of September 1, 2018.

Topics:

  1. Preclinical models
  2. Emerging concepts / novel agents
  3. Microenvironment and immune exclusion
  4. Therapeutic modulation of immune checkpoints
  5. Combination therapy
  6. Anti-cancer vaccines
  7. Oncoloytic viruses
  8. Bi-specific antibodies
  9. Adoptive cell therapy
  10. Monitoring of immunotherapy